Upstate Capital Weekly Newsletter – 1/12/22

Deal Activity Upstate

Two companies have been acquired by public companies in the last couple of weeks: Saratoga-based Century Health and Housing Capital by Velocity Financial and Ellenville-based MMI Agriculture. Both transactions were strategic moves for companies in California and Colorado, respectively. Learn more about finding the right buyer for a business at Upstate Capital’s upcoming M&A Advisor Series.

2022 M&A Slowdown?

Three factors will potentially impact the pace of deal-making in 2022: antitrust efforts, cost of capital, and surprises causing volatility in the market. The NY Times reported on what might cool off the M&A market in the coming months.

Fuzehub Grants Open

The first round of FuzeHub’s 2022 Manufacturing Grants, part of the Jeff Lawrence Innovation Fund, ends on February 4. Click to learn more about eligibility and the application process.

Luminate Applications Due

Working on a technology or application that’s enabled by optics, photonics, or imaging? Luminate can give your startup the immediate funding, support, and investor connections to speed your growth. Applications to Luminate’s six-month accelerator close on Jan. 17 – so get your application in now. It’s not complicated and the benefits are many, including a $100,000 investment at program acceptance, plus a chance to compete for up to $2M in follow-on funding. Space is limited, so apply now. Need more info? Register to attend a free webinar on Jan. 5 (or listen to a previously recorded webinar), or visit Luminate.org.

Join MedTech Association on January 13 at the del Lago Resort in the Finger Lakes Region to celebrate New York’s bio/med industry and recognize the innovators who are driving the state’s life sciences ecosphere. You won’t want to miss this opportunity to network with industry friends, partners, and collaborators. MedTech will recognize nine New York companies, institutions and individuals that have made outstanding contributions to improving health and patient outcomes and for strengthening the state’s bio/med industry.